查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1702349

全球医疗保健市场眼动追踪：2025-2033

Global Eye Tracking in Healthcare Market - 2025-2033
出版日期: | 出版商: DataM Intelligence | 英文 176 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2024 年全球医疗保健眼动追踪市场规模达到 8.0287 亿美元，预计到 2033 年将达到 51.5583 亿美元，在 2025-2033 年预测期内的复合年增长率为 21.4%。

全球医疗保健市场中的眼动追踪利用眼动追踪技术来增强医疗保健服务的各个方面，从诊断工具到改善医疗设备和应用程式的使用者体验。眼动追踪可以测量人的眼睛的运动和焦点，为神经评估、认知障碍诊断和復健治疗提供宝贵的资料。

此技术用于监测眼球运动，以检测中风、失智症和视力障碍等疾病，同时也能深入了解注意力不足过动症或自闭症等精神健康状况。透过追踪患者的关注和关注方式，医疗保健专业人员可以更深入地了解认知和神经健康，从而实现更精确的治疗和诊断。

市场动态：

驾驶员和约束装置

神经系统疾病和认知障碍盛行率上升

神经和认知障碍盛行率的上升是全球医疗保健市场眼动追踪技术发展的关键驱动因素。随着阿兹海默症、帕金森氏症、中风和自闭症谱系障碍 (ASD) 等神经和认知疾病变得越来越普遍，对眼动追踪技术等创新诊断和监测工具的需求也在增加。

眼动追踪透过分析眼球运动为这些疾病提供了宝贵的见解，有助于识别早期迹象并有助于更准确的诊断。例如，世界卫生组织估计，全球约有 5,000 万人患有痴呆症，预计到 2030 年这一数字将上升到 8,200 万人。此外，帕金森氏症影响着全球约 1,000 万人。这些数字强调了医疗保健领域对更好的诊断工具的迫切需求。

眼动追踪技术在评估神经功能、检测认知的早期变化以及提供一种非侵入性的方式来监测病情随时间的发展方面可以发挥关键作用。随着全球人口老化和认知障碍发病率的增加，眼动追踪技术正成为临床医师改善病患照护和提高治疗效果的重要工具。所有这些因素都要求医疗保健市场进行全球眼动追踪。

设备和实施成本高昂

设备和实施的高成本对全球医疗保健市场中的眼动追踪技术造成了重大限制，限制了该技术的广泛应用，尤其是在医疗保健领域。眼动追踪系统，特别是那些为医疗诊断或神经评估而设计的系统，通常涉及高端感测器、专用软体和先进的硬体组件，价格昂贵。

例如，能够检测与神经系统疾病或认知障碍相关的细微眼球运动的临床级系统需要在设备和支援基础设施方面进行大量投资。眼动追踪系统的价格范围为 1.001 美元至 10,000 美元，这可能会对全球医疗保健市场眼动追踪的发展造成限制，因为这些系统虽然适用于某些应用，但可能无法满足更先进的医疗保健诊断所需的精度和可靠性标准。因此，上述因素可能会限制全球医疗保健市场眼动追踪的潜在成长。

目录

第一章：市场介绍和范围

  • 报告目标
  • 报告范围和定义
  • 报告范围

第二章：高阶主管见解与关键要点

  • 市场亮点和战略要点
  • 主要趋势和未来预测
  • 按类型分类的程式码片段
  • 按追踪类型分类的程式码片段
  • 按组件截取片段
  • 按应用程式截取的程式码片段
  • 最终用户的程式码片段
  • 按地区分类的片段

第三章：动态

  • 影响因素
    • 驱动程式
      • 神经系统疾病和认知障碍盛行率上升
      • 眼动追踪技术的进步
    • 限制
      • 设备和实施成本高昂
      • 隐私和资料安全问题
    • 机会
      • 与虚拟实境 (VR) 和扩增实境 (AR) 的集成
    • 影响分析

第四章：战略洞察与产业展望

  • 市场领导者和先驱者
    • 新兴先锋和杰出参与者
    • 拥有最大销售品牌的既定领导者
    • 拥有成熟产品的市场领导者
  • CXO 观点
  • 最新进展与突破
  • 案例研究/正在进行的研究
  • 监管和报销情况
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 波特五力分析
  • 供应链分析
  • 专利分析
  • SWOT分析
  • 未满足的需求和差距
  • 市场进入和扩张的推荐策略
  • 情境分析：最佳情况、基本情况和最坏情况预测
  • 定价分析和价格动态
  • 关键意见领袖

第五章：医疗保健市场中的眼动追踪（按类型）

  • 眼电图（EOG）
    • 追踪
  • 光学追踪
  • 眼动追踪

第六章：医疗保健市场中的眼动追踪（按追踪类型）

  • 远端追踪
  • 行动追踪

第七章：医疗保健市场中的眼动追踪（按组件划分）

  • 硬体
  • 软体

第 8 章：医疗市场中的眼动追踪（按应用）

  • 医学研究与诊断
  • 辅助技术
  • 认知与神经学研究
  • 眼科与视觉科学

第九章：医疗市场中的眼动追踪（按最终用户）

  • 医疗保健提供者
  • 研究机构
  • 辅助设备製造商

第十章：医疗保健市场中的眼动追踪，按区域市场分析和成长机会

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 欧洲其他地区
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 拉丁美洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 中东和非洲

第 11 章：竞争格局与市场定位

  • 竞争概况和主要市场参与者
  • 市占率分析与定位矩阵
  • 策略伙伴关係、併购
  • 产品组合和创新的关键发展
  • 公司基准化分析

第十二章：公司简介

  • Tobii
    • 公司概况
    • 产品组合
      • 产品描述
      • 产品关键绩效指标 (KPI)
      • 历史和预测产品销售
      • 产品销售量
    • 财务概览
      • 公司收入
      • 地区收入份额
      • 收入预测
    • 关键进展
      • 併购
      • 关键产品开发活动
      • 监管部门批准等
    • SWOT分析
  • SR Research Ltd.
  • iMotions
  • Gazepoint
  • EyeTech Digital Systems, Inc.
  • Pupil Labs GmbH.
  • EyeTracking
  • Smart Eye
  • Lumen
  • ERGONEERS GmbH

第十三章：假设与研究方法

  • 资料收集方法
  • 数据三角测量
  • 预测技术
  • 数据验证和确认

第 14 章：附录

简介目录
Product Code: MD9433

The global eye tracking in healthcare market reached US$ 802.87 million in 2024 and is expected to reach US$ 5,155.83 million by 2033, growing at a CAGR of 21.4 % during the forecast period of 2025-2033.

The global eye tracking in healthcare market leverages eye tracking technology to enhance various aspects of healthcare delivery, ranging from diagnostic tools to improving the user experience in medical devices and applications. Eye tracking measures the movement and focus of a person's eyes, providing valuable data for neurological assessments, cognitive disorder diagnoses, and rehabilitation therapy.

This technology is used to monitor eye movements for the detection of conditions such as stroke, dementia, and visual impairments, while also offering insights into mental health conditions like ADHD or autism spectrum disorders. By tracking where and how patients focus, healthcare professionals gain a deeper understanding of cognitive and neurological health, leading to more precise treatments and diagnoses.

Market Dynamics: Drivers & Restraints

Rising Prevalence of Neurological and Cognitive Disorders

The rising prevalence of neurological and cognitive disorders is a key driver in the global eye tracking in healthcare market. As neurological and cognitive conditions such as Alzheimer's disease, Parkinson's disease, stroke, and autism spectrum disorders (ASD) become more common, the demand for innovative diagnostic and monitoring tools, such as eye tracking technology, is increasing.

Eye tracking offers valuable insights into these disorders by analyzing eye movements, helping to identify early signs and aiding in more accurate diagnoses. For instance, the World Health Organization estimates that approximately 50 million people worldwide suffer from dementia, and the number is expected to rise to 82 million by 2030. Additionally, Parkinson's disease affects about 10 million people globally. These numbers underscore the urgent need for better diagnostic tools in the healthcare sector.

Eye tracking can play a critical role in assessing neurological function, detecting early changes in cognition, and offering a non-invasive way to monitor disease progression over time. As the global population ages and the incidence of cognitive disorders increases, eye tracking technology is becoming an essential tool for clinicians aiming to improve patient care and enhance treatment outcomes. All these factors demand global eye tracking in the healthcare market.

High Costs of Equipment and Implementation

The high costs of equipment and implementation pose a significant restraint in the global eye tracking in healthcare market, limiting the widespread adoption of this technology, especially in healthcare settings. Eye tracking systems, particularly those designed for medical diagnostics or neurological assessments, often involve high-end sensors, specialized software, and advanced hardware components that come at a steep price.

For instance, clinical-grade systems capable of detecting subtle eye movements associated with neurological diseases or cognitive disorders require significant investment in both equipment and the infrastructure to support them. The price range of $1.001 to $10,000 for eye tracking systems can act as a restraint in the global eye tracking in healthcare market because these systems, while suitable for certain applications, may not meet the precision and reliability standards required for more advanced healthcare diagnostics. Thus, the above factors could be limiting the global eye tracking in the healthcare market's potential growth.

Segment Analysis

The global eye tracking in healthcare market is segmented based on type, tracking type, component, application, end-user, and region.

Tracking Type:

The remote tracking segment in tracking type is expected to dominate the global eye tracking in healthcare market with the highest market share

The remote tracking segment of the global eye tracking in healthcare market leverages innovative technologies such as cloud computing, mobile devices, and wearable technologies to enable the monitoring of patients' eye movements outside traditional clinical settings.

This capability is crucial in telemedicine platforms, mobile health apps, and home-based monitoring systems. By allowing healthcare providers to track patients from a distance, remote eye tracking can be especially beneficial for continuous monitoring of those with neurological conditions, cognitive disorders, or individuals undergoing rehabilitation therapies.

It eliminates the need for patients to visit healthcare facilities regularly, improving access to care and enhancing patient convenience. This is especially important as patients, particularly those with chronic conditions, can experience fluctuations in symptoms that require consistent tracking.

By enabling eye movement analysis outside of medical environments, remote tracking technology offers greater flexibility in patient care and supports early detection of changes in cognitive or neurological health. It also allows for real-time data collection, making it easier to adjust treatment plans or interventions based on immediate insights. These factors have solidified the segment's position in the global eye tracking in healthcare market.

Geographical Analysis

North America is expected to hold a significant position in the global eye tracking in healthcare market, with the highest market share

The North American eye tracking in healthcare market is being driven by several factors. One of the key drivers is the increasing application of eye tracking technology in the healthcare sector, particularly for diagnosing and monitoring neurological disorders like Parkinson's disease, Alzheimer's, and other cognitive impairments. This technology provides valuable insights into eye movements and gaze patterns, which help in early detection and assessment, enhancing the effectiveness of treatment and rehabilitation.

Furthermore, North America's advanced healthcare system and technological infrastructure play a significant role in driving the market. The region is home to leading research institutions and healthcare providers that integrate eye tracking into clinical practices, such as in cognitive rehabilitation and assistive devices for patients with severe motor disabilities.

The region is also seeing increased adoption in consumer electronics, gaming, and the automotive industry, all of which are contributing to the broader use of eye tracking in healthcare settings. Thus, the above factors are consolidating the region's position as a dominant force in the global eye tracking in healthcare market.

Competitive Landscape

The major global players in the eye tracking in healthcare market include Tobii, SR Research Ltd., iMotions, Gazepoint, EyeTech Digital Systems, Inc., Pupil Labs GmbH, EyeTracking, Smart Eye, Lumen, and ERGONEERS GmbH, among others.

Key Developments

  • In February 2024, Visage Imaging, Inc. unveiled the innovative Visage Ease VP for Apple Vision Pro, Apple's much-awaited spatial computing platform. Tailored to leverage the distinct features of Apple Vision Pro, Visage Ease VP enables immersive, spatial interactions for diagnostic imaging and multimedia applications.
  • In January 2024, Tobii's launch of the UX Explore cloud platform, designed to enhance mobile user experience (UX) research with eye-tracking technology, is a significant development that could positively impact the global eye-tracking in healthcare market. This cloud-based solution allows for more scalable, efficient, and accessible UX research, enabling healthcare professionals and developers to evaluate the user experience of mobile healthcare applications, telemedicine platforms, and digital health devices with greater ease.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials and product pipelines and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzed product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: This covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyze competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global eye tracking in healthcare market report delivers a detailed analysis with 78 key tables, more than 71 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

  • 1.1. Objectives of the Report
  • 1.2. Report Coverage & Definitions
  • 1.3. Report Scope

2. Executive Insights and Key Takeaways

  • 2.1. Market Highlights and Strategic Takeaways
  • 2.2. Key Trends and Future Projections
  • 2.3. Snippet by Type
  • 2.4. Snippet by Tracking Type
  • 2.5. Snippet by Component
  • 2.6. Snippet by Application
  • 2.7. Snippet by End-User
  • 2.8. Snippet by Region

3. Dynamics

  • 3.1. Impacting Factors
    • 3.1.1. Drivers
      • 3.1.1.1. Rising Prevalence of Neurological and Cognitive Disorders
      • 3.1.1.2. Advancements in Eye Tracking Technology
    • 3.1.2. Restraints
      • 3.1.2.1. High Costs of Equipment and Implementation
      • 3.1.2.2. Privacy and Data Security Concerns
    • 3.1.3. Opportunity
      • 3.1.3.1. Integration with Virtual Reality (VR) and Augmented Reality (AR)
    • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

  • 4.1. Market Leaders and Pioneers
    • 4.1.1. Emerging Pioneers and Prominent Players
    • 4.1.2. Established leaders with the largest-selling Brand
    • 4.1.3. Market leaders with established Product
  • 4.2. CXO Perspectives
  • 4.3. Latest Developments and Breakthroughs
  • 4.4. Case Studies/Ongoing Research
  • 4.5. Regulatory and Reimbursement Landscape
    • 4.5.1. North America
    • 4.5.2. Europe
    • 4.5.3. Asia Pacific
    • 4.5.4. Latin America
    • 4.5.5. Middle East & Africa
  • 4.6. Porter's Five Forces Analysis
  • 4.7. Supply Chain Analysis
  • 4.8. Patent Analysis
  • 4.9. SWOT Analysis
  • 4.10. Unmet Needs and Gaps
  • 4.11. Recommended Strategies for Market Entry and Expansion
  • 4.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 4.13. Pricing Analysis and Price Dynamics
  • 4.14. Key Opinion Leaders

5. Eye Tracking in Healthcare Market, By Type

  • 5.1. Introduction
    • 5.1.1. Analysis and Y-o-Y Growth Analysis (%), By Type
    • 5.1.2. Market Attractiveness Index, By Type
  • 5.2. Electrooculography (EOG)*
    • 5.2.1. Introduction
    • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 5.2.3. Tracking
  • 5.3. Optical Tracking
  • 5.4. Eye-Attached Tracking

6. Eye Tracking in Healthcare Market, By Tracking Type

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Tracking Type
    • 6.1.2. Market Attractiveness Index, By Tracking Type
  • 6.2. Remote Tracking*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Mobile Tracking

7. Eye Tracking in Healthcare Market, By Component

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 7.1.2. Market Attractiveness Index, By Component
  • 7.2. Hardware*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Software

8. Eye Tracking in Healthcare Market, By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Medical Research & Diagnostics*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Assistive Technology
  • 8.4. Cognitive & Neurological Studies
  • 8.5. Ophthalmology & Vision Science

9. Eye Tracking in Healthcare Market, By End-User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.1.2. Market Attractiveness Index, By End-User
  • 9.2. Healthcare Providers*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Research Institutes
  • 9.4. Assistive Device Manufacturers

10. Eye Tracking in Healthcare Market, By Regional Market Analysis and Growth Opportunities

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Tracking Type
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.8.1. U.S.
      • 10.2.8.2. Canada
      • 10.2.8.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Tracking Type
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.8.1. Germany
      • 10.3.8.2. U.K.
      • 10.3.8.3. France
      • 10.3.8.4. Spain
      • 10.3.8.5. Italy
      • 10.3.8.6. Rest of Europe
  • 10.4. Latin America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Tracking Type
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.8.1. Brazil
      • 10.4.8.2. Argentina
      • 10.4.8.3. Rest of Latin America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Tracking Type
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.8.1. China
      • 10.5.8.2. India
      • 10.5.8.3. Japan
      • 10.5.8.4. South Korea
      • 10.5.8.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Tracking Type
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape and Market Positioning

  • 11.1. Competitive Overview and Key Market Players
  • 11.2. Market Share Analysis and Positioning Matrix
  • 11.3. Strategic Partnerships, Mergers & Acquisitions
  • 11.4. Key Developments in Product Portfolios and Innovations
  • 11.5. Company Benchmarking

12. Company Profiles

  • 12.1. Tobii*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio
      • 12.1.2.1. Product Description
      • 12.1.2.2. Product Key Performance Indicators (KPIs)
      • 12.1.2.3. Historic and Forecasted Product Sales
      • 12.1.2.4. Product Sales Volume
    • 12.1.3. Financial Overview
      • 12.1.3.1. Company Revenue
      • 12.1.3.2. Geographical Revenue Shares
      • 12.1.3.3. Revenue Forecasts
    • 12.1.4. Key Developments
      • 12.1.4.1. Mergers & Acquisitions
      • 12.1.4.2. Key Product Development Activities
      • 12.1.4.3. Regulatory Approvals, etc.
    • 12.1.5. SWOT Analysis
  • 12.2. SR Research Ltd.
  • 12.3. iMotions
  • 12.4. Gazepoint
  • 12.5. EyeTech Digital Systems, Inc.
  • 12.6. Pupil Labs GmbH.
  • 12.7. EyeTracking
  • 12.8. Smart Eye
  • 12.9. Lumen
  • 12.10. ERGONEERS GmbH

LIST NOT EXHAUSTIVE

13. Assumptions and Research Methodology

  • 13.1. Data Collection Methods
  • 13.2. Data Triangulation
  • 13.3. Forecasting Techniques
  • 13.4. Data Verification and Validation

14. Appendix

  • 14.1. About Us and Services
  • 14.2. Contact Us